Editorial: Molecular targets for the treatment of metastatic colorectal cancer

Alessandro Passardi; David Gibbons

doi:10.3389/fonc.2023.1341594

Editorial: Molecular targets for the treatment of metastatic colorectal cancer

Front Oncol. 2023 Dec 12:13:1341594. doi: 10.3389/fonc.2023.1341594. eCollection 2023.

Authors

Alessandro Passardi¹, David Gibbons^{2

3}

Affiliations

¹ Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
² Department of Pathology, St Vincent's University Hospital, Dublin, Ireland.
³ School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.

No abstract available

Keywords: BRAF V600E; EGFR inhibitiors; angiogenesis; colorectal cancer; immunocheck point inhibitors; metastatic colon cancer; molecular targets; refractory colorectal cancer.

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.